Weight change between successive pregnancies and risks of stillbirth and infant mortality: a nationwide cohort study


Maternal overweight and obesity are risk factors for stillbirth and infant mortality. Whether temporal changes in maternal weight affect these risks is not clear. We aimed to assess whether change of BMI between first and second pregnancies affects risks of stillbirth and infant mortality in the second-born offspring.


In a Swedish population-based cohort of women who gave birth to their first and second child between Jan 1, 1992, and Dec 31, 2012, we investigated associations between change in maternal body-mass index (BMI) during early pregnancy from first to second pregnancies and risks of stillbirth and neonatal, postneonatal, and infant mortality after the second pregnancy. Relative risks (RRs) for each outcome according to BMI change categories were calculated with binomial regression.


Complete information was available for 456 711 (77·7%) of 587 710 women who had their first and second single births in the study period. Compared with women with a stable BMI (change between −1 kg/m2 and <1 kg/m2) between pregnancies, the adjusted RRs for women who gained at least 4 BMI units between pregnancies were 1·55 (95% CI 1·23–1·96) for stillbirth and 1·29 (1·00–1·67) for infant mortality. Stillbirth risks increased linearly with increased BMI gain. Risks of infant mortality in second pregnancy only increased with BMI gain in women with healthy BMI (<25 kg/m2) during first pregnancy; the adjusted RR for healthy weight women who gained 2 to less than 4 BMI units was 1·27 (1·01–1·59) and for those who gained 4 BMI units or more the adjusted RR was 1·60 (1·16–2·22). In overweight women (BMI ≥25 kg/m2), weight loss before pregnancy reduced risk of neonatal mortality.


Our findings emphasise the need to prevent weight gain before pregnancy in healthy and overweight women and that weight loss should be promoted in overweight women.


Swedish Research Council for Health, Working Life and Welfare, and Karolinska Institutet.

By Sven Chattingius & Eduardo Villamor, The Lancet Volume 387, No. 10018, p558–565, 6 February 2016


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s